Meso Numismatics Inc (MSSV)
0.0449
+0.01
(+24.72%)
USD |
OTCM |
May 10, 14:18
Meso Numismatics Gross Profit Margin (Quarterly): 70.63% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 70.63% |
| September 30, 2023 | 69.62% |
| June 30, 2023 | 70.24% |
| March 31, 2023 | 68.28% |
| December 31, 2022 | 63.37% |
| September 30, 2022 | 72.05% |
| June 30, 2022 | 49.40% |
| March 31, 2022 | 35.57% |
| December 31, 2021 | 31.69% |
| September 30, 2021 | 46.37% |
| June 30, 2021 | 24.79% |
| March 31, 2021 | -232.9% |
| Date | Value |
|---|---|
| December 31, 2020 | 6.83% |
| September 30, 2020 | 15.15% |
| June 30, 2020 | 34.33% |
| March 31, 2020 | -7.06% |
| December 31, 2019 | 41.24% |
| September 30, 2019 | -254.2% |
| June 30, 2019 | -108.3% |
| March 31, 2019 | -31.82% |
| December 31, 2018 | -335.1% |
| September 30, 2018 | 42.16% |
| June 30, 2018 | 36.24% |
| March 31, 2018 | 74.69% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-254.2%
Minimum
Sep 2019
72.05%
Maximum
Sep 2022
5.11%
Average
35.57%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 81.54% |
| IGC Pharma Inc | 65.20% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Protalix BioTherapeutics Inc | 15.54% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -164.2% |
| Profit Margin (Quarterly) | -41.59% |
| Operating Margin (Quarterly) | -21.95% |
| Return on Net Operating Assets | -207.3% |